<DOC>
	<DOCNO>NCT01360749</DOCNO>
	<brief_summary>Double-blind , randomize , placebo-controlled trial ass efficacy Lambdalina ( lidocaine cream ) reduce pain associate laser hair removal woman .</brief_summary>
	<brief_title>Efficacy Safety Lambdalina ( Lidocaine Cream ) Versus Placebo Anesthetic Laser Hair Removal</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>1 . Women ≥ 18 ≤ 65 year old . 2 . Laser hair removal treatment session legs area knee ankle ( first second application ) . 3 . Able accomplish study 's requirement . 4 . Negative result pregnancy test . 5 . Sterile surgically sterilize woman ( hysterectomy , tubal ligation ) use adequate contraceptive method . 6 . Written inform consent prior inclusion trial . General exclusion criterion : 1 . Pregnant breastfeeding . Current previous medical condition : 2 . Skin type 5 6 history photosensitivity . 3 . Cardiovascular disease unstable angina , severe heart failure ( New York Heart Association III IV ) . 4 . Neuropathy paresthesia . 5 . History hepatic failure . 6 . Autoimmune diseases . 7 . Allergies peanuts and/or soy and/or component formulation . 8 . Use dependence prohibit substance . 9 . Other contraindication specify summary product characteristic . Current previous concomitant medication : 10 . Any anesthetic analgesic treatment 2 hour prior study entry . 11 . Concomitant treatment antiarrhythmic drug class I ( eg . tocainide , mexiletine ) class III ( eg . amiodarone , sotalol ) , anticoagulant , antiplatelet aggregate and/or betablockers . 12 . Active wound irritation area treat . 13 . Topical treatment corticosteroid topical agent area study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Pain management</keyword>
	<keyword>Lidocaine</keyword>
</DOC>